Ben Greenfield: “Oil Changes” For Your Blood, DIRTY Pharmaceutical Secrets, AI-Powered Medicine & More
Peer-Reviewed Research
Key Takeaways
- Rebates drive up drug costs – Insurance companies negotiate kickbacks (rebates) from pharmaceutical companies, artificially inflating prices (e.g., insulin costs 10X more despite cheap production).
- Muse cells show promise – Non-tumorigenic in studies, and early research indicates they may shrink tumors and modulate immune response in cancer models.
Notable Quotes
“Instead of selling it for $150, sell it to us for $300, give us a $150 rebate.”
Bottom Line
Research drug pricing transparency and emerging cell therapies like Muse for potential health applications, but verify safety and efficacy in human trials.
Explore More
- Ben Greenfield’s Full Protocol — supplements, dosages, and daily routine
- Compare All Protocols — side-by-side protocols
Watch the Full Video
Medical Disclaimer
This article is for informational purposes only and does not constitute medical advice. The research summaries presented here are based on published studies and should not be used as a substitute for professional medical consultation. Always consult a qualified healthcare provider before making any changes to your health regimen.
Peer-reviewed health research, simplified. Early access findings, clinical trial alerts & regulatory news — delivered weekly.
No spam. Unsubscribe anytime. Powered by Beehiiv.
Related Research
From Our Research Network
Daily longevity researchZone2 Training
Exercise protocolsSleep Science
Sleep optimization
Part of the Evidence-Based Research Network